| Stephen Henson, MD | |
|
2600 Greenbush St, Lafayette, IN 47904-2479 | |
| (765) 448-8000 | |
| (765) 448-7625 |
| Full Name | Stephen Henson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 2600 Greenbush St, Lafayette, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902875586 | NPI | - | NPPES |
| 10825262 | Other | IN | CAQH NUMBER |
| HE80478004 | Medicaid | IN | |
| 100231190 | Medicaid | IN | |
| 000000179580 | Other | IN | ANTHEM PROVIDER NUMBER |
| 9039384 | Other | IN | PHCS PID NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 010280084A (Indiana) | Primary |
| Entity Name | Arnett Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164490843 PECOS PAC ID: 0749184380 Enrollment ID: O20031125000119 |
News Archive
A cell type that causes significant scarring in lung disease appears to have a similar effect in Graves' disease, University of Michigan Health System researchers have found. The cells, called fibrocytes, are present at a higher than normal frequency in patients with Graves' disease, according to a new study, the first to associate fibrocytes with this autoimmune disease.
Quest Diagnostics, the world's leading provider of diagnostic information services, and Inserm, the French National Institute of Health and Medical Research institution, today launched BRCA Share, a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data.
Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.
Melbourne researchers have showed that they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Henson, MD 1200 W White River Blvd, Muncie, IN 47303-4988 Ph: (877) 668-5621 | Stephen Henson, MD 2600 Greenbush St, Lafayette, IN 47904-2479 Ph: (765) 448-8000 |
News Archive
A cell type that causes significant scarring in lung disease appears to have a similar effect in Graves' disease, University of Michigan Health System researchers have found. The cells, called fibrocytes, are present at a higher than normal frequency in patients with Graves' disease, according to a new study, the first to associate fibrocytes with this autoimmune disease.
Quest Diagnostics, the world's leading provider of diagnostic information services, and Inserm, the French National Institute of Health and Medical Research institution, today launched BRCA Share, a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data.
Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.
Melbourne researchers have showed that they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.
› Verified 6 days ago
Peter J Hillsamer, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2320 Concord Rd, Lafayette, IN 47909 Phone: 765-477-7436 Fax: 765-477-1245 | |
Paul Forrestal Wilson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2320 Concord Rd, Lafayette, IN 47909 Phone: 765-477-7436 Fax: 765-477-1245 | |
Dr. Don R Jaffe, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5165 Mccarty Ln, Lafayette, IN 47905 Phone: 765-838-5842 Fax: 765-838-4771 | |
Dr. Kyle D. Loy, M.D. P.C. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2606 Veterans Memorial Pkwy S, Suite 1, Lafayette, IN 47909 Phone: 765-474-4500 Fax: 765-474-1122 | |
Thomas Francis Brennan, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7625 | |
Aaron Joel Duberstein, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2320 Concord Rd, Lafayette, IN 47909 Phone: 765-477-7436 Fax: 765-477-1245 | |
Dr. Timothy M Cupero, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush Street, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7625 |